Patent details
300797 Product Name: Sufentanil, desgewenst in de vorm van sufentanilcitraat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300797
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP2114383
- Status:
- Withdrawn
- Application number:
- 300797
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1042
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 22/09/2015
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 24/02/2016
- First Marketing Authorization date:
- 22/09/2015
- Grant date:
- Activation date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 04/03/2016
- SPC/SPC Extension Expiration Date:
- 21/09/2030
- Lapsed By Expiration Date:
- Withdrawal date:
- 27/08/2020
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 24/02/2016
- Name:
- Acelrx Pharmaceuticals, Inc.
- Address:
- 351 Galveston Drive, REDWOOD CITY, CA 94063 , United States of America (US)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 04/03/2016
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 36/20
- Publication date:
- 02/09/2020
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 10/16
- Publication date:
- 09/03/2016
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 27/08/2020 | SPC Documents | Withdrawal SPC | 1 | /3/4/5/4/3/0800034543/docs/300797_2_supplprotectioncertificate20200827120547074.pdf | ||
| 27/08/2020 | Outgoing Correspondence | Letter confirmation withdrawal | 1 | /3/4/5/4/3/0800034543/docs/300797_8_363104l193.pdf | ||
| 14/07/2020 | SPC Documents | Annex SPC | 2 | /3/4/5/4/3/0800034543/docs/300797_1_supplprotectioncertificate20200714022033080.pdf | ||
| 14/07/2020 | Outgoing Correspondence | Letter to applicant | 2 | /3/4/5/4/3/0800034543/docs/300797_3_354127l173.pdf | ||
| 14/07/2020 | SPC Documents | Annex SPC | 13 | /3/4/5/4/3/0800034543/docs/300797_6_supplprotectioncertificate20200714021932074.pdf | ||
| 04/03/2016 | Outgoing Correspondence | Outgoing Letter | 1 | /3/4/5/4/3/0800034543/docs/300797_9_40046l174.pdf | ||
| 24/02/2016 | SPC Documents | Summary of the characteristics of the product | 14 | /3/4/5/4/3/0800034543/docs/300797_0_supplprotectioncertificate20200412100526374.pdf | ||
| 24/02/2016 | SPC Documents | Annex SPC | 1 | /3/4/5/4/3/0800034543/docs/300797_4_supplprotectioncertificate20200412100731382.pdf | ||
| 24/02/2016 | SPC Documents | Marketing Authorization SPC | 3 | /3/4/5/4/3/0800034543/docs/300797_5_supplprotectioncertificate20160304103816104.pdf | ||
| 24/02/2016 | Application Form | First filed application form | 3 | /3/4/5/4/3/0800034543/docs/300797_7_applicationform20160304103815939.pdf |